News
Concord Biotech consolidated net profit rises 11.12% in the September 2026 quarter
28-Oct-2026 | 07:45
Sales rise 25.10% to Rs 309.07 crore
Net profit of Concord Biotech rose 11.12% to Rs 70.65 crore in the quarter ended September 2026 as against Rs 63.58 crore during the previous quarter ended September 2025. Sales rose 25.10% to Rs 309.07 crore in the quarter ended September 2026 as against Rs 247.06 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 309.07 | 247.06 | 25 |
| OPM % | 33.56 | 35.82 | - |
| PBDT | 113.86 | 104.08 | 9 |
| PBT | 95.48 | 85.68 | 11 |
| NP | 70.65 | 63.58 | 11 |
Powered by Capital Market - Live News